Indivior PLC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Indivior Pharmaceuticals reports a successful 2025, marked by significant revenue growth, increased profitability, and strategic advancements in its U.S. SUBLOCADE business.